Home › Stomach Cancer › Texas › Austin
Stomach Cancer clinical trials in Austin, TX
10 studies for Stomach Cancer are looking for participants at sites in and around Austin (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RecruitingPhase 1
- NEXT Oncology, Austin
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
RecruitingPhase 2/3
- Texas Oncology-Austin Central, Austin
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RecruitingPhase 1/2
- Texas Oncology (Balcones) - SCRI, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RecruitingPhase 1
- NEXT Oncology - Austin, Austin
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RecruitingPhase 1
- NEXT Austin, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Texas Oncology - Central South, Austin
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
RecruitingPhase 1
- NEXT Oncology Austin /ID# 243005, Austin
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
RecruitingPhase 3
- Texas Oncology Central South (SCRI), Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Elligo Health Research, Inc., Austin
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RecruitingPhase 1
- Dren Investigational Site, Austin
About Stomach Cancer
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
More about Stomach Cancer on MedlinePlus
Stomach Cancer trials in other cities
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA22 studies
- Baldwin Park, CA22 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- Grand Rapids, MI18 studies
- St. Louis, MO18 studies
- Washington, DC16 studies
Other studies in Austin
- Non-Small Cell Lung Cancer30 studies
- Cancer (all types)20 studies
- Obesity20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer19 studies
- Heart Failure18 studies
- Breast Cancer18 studies
- Overweight18 studies
- Ovarian Cancer17 studies
- Endometrial Cancer15 studies
- Prostate Cancer15 studies
- Depression14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.